Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000464858 | SCV000557963 | likely benign | Hypertrophic cardiomyopathy | 2023-12-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620466 | SCV000735765 | likely benign | Cardiovascular phenotype | 2017-02-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV001181138 | SCV001346225 | likely benign | Cardiomyopathy | 2019-07-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001557656 | SCV001779453 | likely benign | not provided | 2020-03-10 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002489107 | SCV002803170 | likely benign | Hypertrophic cardiomyopathy 1; Myopathy, myosin storage, autosomal recessive; Myosin storage myopathy; Congenital myopathy with fiber type disproportion; Dilated cardiomyopathy 1S; MYH7-related skeletal myopathy | 2021-07-28 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001181138 | SCV004816465 | likely benign | Cardiomyopathy | 2023-11-30 | criteria provided, single submitter | clinical testing |